Wednesday, June 10, 2026
🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,492

Quick answer

1,492 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7772271

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7763259

    Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

    The Regents of the University of Colorado · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7758876

    Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7754420

    Methods of using cyanovirins to inhibit viral infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7749983

    Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates

    The Regents of the University of California · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7745418

    Compositions and methods for inhibiting viral replication

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7740889

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7737124

    Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

    The Regents of the University of California · Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7731971

    Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7732207

    Method for expression of small antiviral RNA molecules within a cell

    The Regents of the University of California · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7728148

    Acyclic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7727970

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted to Hepatitis C virus

    Benitec, Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7718183

    Proteins with repetitive bacterial-Ig-like (big) domains present in Leptospira species

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7718769

    Tri-peptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7718610

    Retrocyclins: antiviral and antimicrobial peptides

    The Regents of the University of California · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7718612

    Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7713529

    Methods for treating and preventing infectious disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7714137

    Pyridyl substituted heterocycles useful for treating or preventing HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7704976

    Use of N-acetyl-D-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention

    Third Military Medical University, Chinese People's Liberation Army, P.R. of China · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7700273

    Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human immunodeficiency virus (HIV) CCR5 coreceptor

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7687459

    Arylalkoxyl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7678569

    Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7670855

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7666581

    Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease

    University of Connecticut Health Center · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7666619

    Compounds and methods for regulating bacterial growth and pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7666427

    HIV vaccines based on Env of multiple clades of HIV

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7662607

    Chalaropsis lysozyme protein and its method of use in anti-bacterial applications

    New Century Pharmaceuticals, Inc. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7662779

    Triazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7662999

    Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases

    The United States of America as represented by the Department of Health and Human Services (DHHS) · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7655247

    Malaria vaccines

    The Government of the United States, as Respresented by the Secretary of the Army · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7645881

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7645732

    Treating hepatitis C virus infection

    The Board of Regents of the University of Texas System · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7638269

    Viral capsid assembly intermediates and methods of production

    The Regents of the University of California · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7635476

    Anti-hepatitis a virus antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7635688

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7635683

    Quinoxalinyl tripeptide hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7625871

    Indole antiviral compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7618623

    Hybrid adeno-retroviral vector for the transfection of cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7611885

    Pharmaceutically compatible method for purifying intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7612093

    Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapy

    United Therapeutics Corporation · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7611704

    Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7605126

    Acylaminoheteroaryl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7601735

    Antiviral compounds

    Airgain, Inc. · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7601490

    Development of influenza A antivirals

    The Board of Regents of the University of Texas System · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7601709

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7589075

    Use of an adenosine A3 receptor agonist for inhibition of viral replication

    CAN-FITE BIOPHARMA LTD. · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7582605

    Phosphorus-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7572828

    Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Infectious disease patents are indexed?

1,492 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.